The Pharma Letter It is projected that the heparin active pharmaceutical ingredient (API) in China will achieve an additional capacity of more than 20 trillion units b...
Anesthesiology News “Currently, there is insufficient data regarding the risk of neuraxial hematoma for analgesia in conjunction with heparin administered three times daily,” noted Jackson Su, MD, assistant professor of anesthesiology and perioperative medicine at the ...
FiercePharma Manufacturing After tainted Chinese heparin in 2008 led to dozens of deaths of dialysis patients in the U.S., global regulators started preaching loud and clear on the need for heparin makers to be able to track back sources to ensure they were safe. German meat ...
In-PharmaTechnologist.com The resulting crude heparin will be processed into API at Pharma Action's refinement plant in Berlin, which has capacity to produce 10 tonnes...
MedPage Today Low-molecular weight heparin might be more cost-effective than unfractionated heparin for venous thromboembolism (VTE) prevention in critical illness, ...
In-PharmaTechnologist.com Heparin production may be moving back to Europe according to the EFCG, which cited the opening of Pharma Action's processing plant as an indication that API buyers value quality and compliance throughout the supply chain. and more »
WhaTech In terms of the proposed/ongoing projects, however, it is projected that the heparin API in China will achieve an additional capacity of more than 20 trillion units by 2015, when China's total capacity will exceed 30 trillion units, accounting for ...
The Biological SCENE A research team led by Jayachandran N. Kizhakkedathu of the University of British Columbia recently designed a reversal agent for heparin (Sci. Tr...
